Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Humacyte, Inc. Common Stock
IPO Date: November 30, 2020
Sector: Healthcare
Industry: Biotech
Market Cap: $353.67M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.19 | 3.86%
Avg Daily Range (30 D): $0.08 | 3.38%
Avg Daily Range (90 D): $0.09 | 4.38%
Institutional Daily Volume
Avg Daily Volume: 1.37M
Avg Daily Volume (30 D): 3.13M
Avg Daily Volume (90 D): 4.06M
Trade Size
Avg Trade Size (Sh.): 162
Avg Trade Size (Sh.) (30 D): 241
Avg Trade Size (Sh.) (90 D): 279
Institutional Trades
Total Inst.Trades: 292
Avg Inst. Trade: $1.45M
Avg Inst. Trade (30 D): $1.75M
Avg Inst. Trade (90 D): $1.47M
Avg Inst. Trade Volume: .31M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.56M
Avg Closing Trade (30 D): $2.67M
Avg Closing Trade (90 D): $1.92M
Avg Closing Volume: 314.79K
   
News
Mar 26, 2025 @ 10:18 AM
US Stocks Likely To Open Lower After 3-Day Advance...
Source: Rishabh Mishra
Jan 21, 2025 @ 3:44 PM
DEADLINE ALERT for WOLF, HUMA, XRX, and ZETA: The ...
Source: The Law Offices Of Frank R. Cruz
Jan 17, 2025 @ 5:28 PM
HUMA Investors Have Opportunity to Lead Humacyte, ...
Source: Business Wire
Jan 17, 2025 @ 3:47 PM
HUMA DEADLINE TODAY: ROSEN, A TOP RANKED LAW FIRM,...
Source: N/A
Jan 13, 2025 @ 5:14 PM
Humacyte, Inc. (HUMA) Investors Who Lost Money Hav...
Source: Prnewswire
Financials
  TTM Q4 2024 FY 2024
Basic EPS $.28 $-.16 $-1.26
Diluted EPS $.28 $-.16 $-1.26
Revenue $ .52M $ M $ M
Gross Profit $ .37M $ $
Net Income / Loss $ 39.14M $ -20.94M $ -148.7M
Operating Income / Loss $ -23.18M $ -28.09M $ -114.4M
Cost of Revenue $ .15M $ $
Net Cash Flow $ 17.91M $ 24.37M $ 14.49M
PE Ratio 9.45